Monges Viviane sold $396K of PHVS
Monges Viviane sold 11,969 shares of Pharvaris N.V. (PHVS) at $33.05 ($0.40M total) on 2026-09-23.
How this was made
The 30-second read
Why it matters
The director's reduction in holdings is modest and unlikely to affect market perception.
Market read
Primary relevance is to traders monitoring insider activity; broader market impact is negligible.
What to watch
Potential upcoming dilution or financing events not disclosed in this filing.
Background
SEC Form 4 filings disclose insider transactions; this is the first public report of this sale.
Ticker impact
Director Viviane Monges sold 11,969 shares for $395,524, reducing her stake to 5,500 shares.
Minimal impact; price may dip slightly on short-term supply pressure.
Sale size is under $1M and represents a small portion of total shares; no broader market implications.
Market effects
None; the transaction is company‑specific.
No regional effect.
Limited to investors tracking insider activity.
Counterpoint
The sale could signal insider concern, but size is too small to warrant a contrarian short.
Key entities
- CompanyPharvaris N.V.
Biotech firm listed on Nasdaq under ticker PHVS.
- InsiderViviane Monges
Director of Pharvaris N.V.
